Harel Insurance Investments & Financial Services’s Sarepta Therapeutics SRPT Stock Holding History

Harel Insurance Investments & Financial Services’s Portfolio SRPT Stock Details SRPT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-9	Closed	-$1K	–	794
2022 Q1	$1K	Buy	+9	New	+$689	﹤0.01%	695
2019 Q4	–	Sell	-83	Closed	-$6K	–	552
2019 Q3	$6K	Sell	83 -700	-89%	-$82.7K	﹤0.01%	468
2019 Q2	$119K	Buy	783 +695	+790%	+$84.5K	0.01%	231
2019 Q1	$10K	Sell	88 -1,884	-96%	-$242K	﹤0.01%	403
2018 Q4	$215K	Buy	1,972 +1,042	+112%	+$130K	0.01%	171
2018 Q3	$147K	Buy	930 +180	+24%	+$24.6K	0.01%	231
2018 Q2	$99K	Buy	+750	New	+$70.7K	0.01%	246

Other funds holding SRPT

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return

EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

CCM

Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return

Harel Insurance Investments & Financial Services's SRPT Position: Q2 2022 in Review

Harel Insurance Investments & Financial Services sold out of Sarepta Therapeutics (SRPT) in Q2 2022, closing a stake of 9 shares — an estimated $1K sold.

Harel Insurance Investments & Financial Services first reported a position in SRPT in Q2 2018 and held it in 7 quarters. The position peaked at $215K in Q4 2018. 332 funds tracked by Wall St. Rank hold SRPT as of Q2 2022.

Harel Insurance Investments & Financial Services reported no remaining Sarepta Therapeutics position as of Q2 2022 after selling out during the quarter.
Harel Insurance Investments & Financial Services sold 9 Sarepta Therapeutics shares in Q2 2022, an estimated $1K.
Harel Insurance Investments & Financial Services first reported a position in Sarepta Therapeutics in Q2 2018 and held it in 7 quarters.
Harel Insurance Investments & Financial Services's Sarepta Therapeutics position peaked at $215K in Q4 2018.
332 funds tracked by Wall St. Rank held Sarepta Therapeutics as of Q2 2022.

Based on Harel Insurance Investments & Financial Services's 13F filing for Q2 2022, filed 19 Jul 2022.